
Moderna Inc (NASDAQ:MRNA) has asked the FDA to authorize a second booster dose of its COVID-19 vaccine for adults in the U.S.
Moderna said that the dose could be given to anyone who received an initial booster shot of any authorized COVID-19 vaccines.